This finding suggests that FGF5 may be intricately involved in the processes leading to treatment resistance, potentially through its regulation of the tumor microenvironment and interaction with cancer-associated fibroblasts (CAFs) [29]. This evidence concerns the gene FGF5 and neoplasm.